Pictet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63M | Buy |
208,266
+1,223
| +0.6% | +$370K | 0.06% | 279 |
|
|
2025
Q1 | $68.5M | Sell |
207,043
-1,441
| -0.7% | -$477K | 0.08% | 256 |
|
|
2024
Q4 | $64.3M | Buy |
208,484
+57,886
| +38% | +$17.9M | 0.07% | 261 |
|
|
2024
Q3 | $32M | Buy |
150,598
+13,323
| +10% | +$2.83M | 0.04% | 378 |
|
|
2024
Q2 | $38.5M | Sell |
137,275
-46,888
| -25% | -$13.1M | 0.04% | 328 |
|
|
2024
Q1 | $48.4M | Buy |
184,163
+12,998
| +8% | +$3.42M | 0.05% | 314 |
|
|
2023
Q4 | $39.6M | Buy |
171,165
+59,740
| +54% | +$13.8M | 0.04% | 346 |
|
|
2023
Q3 | $16.3M | Buy |
+111,425
| New | +$16.3M | 0.02% | 513 |
|